Ovid Therapeutics Inc (OVID) PT Raised to $12 at JMP Securities Jul 13, 2020 02:10PM
Ovid Therapeutics (OVID) Prices 9M Share Common Offering at $2.50/Sh; Announces Pricing on Concurrent 4,000 Series A Convertible Preferred Share Offering Oct 4, 2019 08:34AM
Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock Oct 4, 2019 08:30AM
Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock Oct 4, 2019 08:30AM
Ovid Therapeutics Inc (OVID) PT Lowered to $11 at JMP Securities Mar 8, 2019 03:17AM


Feb 20, 2019 09:12AM UPDATE: Ovid Therapeutics (OVID) Prices 12.5M Share Common Offering at $2/Sh; Announces Pricing of 2500 Preferred Share Offering
Feb 20, 2019 09:08AM Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
Feb 20, 2019 09:08AM Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
Jun 12, 2017 04:05PM Ovid Therapeutics to Participate in the JMP Securities 2017 Life Sciences Conference
May 30, 2017 04:04AM JMP Securities Starts Ovid Therapeutics Inc (OVID) at Market Outperform, "Building a Leader in Orphan Neurology"
May 5, 2017 10:43AM Ovid Therapeutics (OVID) IPO Opens 7% Lower
May 4, 2017 06:20PM Ovid Therapeutics Announces Pricing of Initial Public Offering